Thought Leadership Article for Ark Surgical

As part of ongoing collaboration with Ark Surgical, ELAFY developed a thought leadership article addressing one of the most critical and evolving topics in gynecologic surgery: tissue dissemination risk in laparoscopic morcellation and the role of containment.

Published in Patient Safety & Quality Healthcare (PSQH), the article reframes containment not solely as a surgical technique, but as a broader institutional governance and risk management decision.

The piece explores how variability in containment practices, documentation, and device selection may impact not only clinical outcomes but also oncologic risk, patient safety, and institutional liability. It highlights that tissue dissemination is not limited to rare malignancies, but also includes benign conditions that may lead to recurrence, additional procedures, and increased disease burden.

Drawing on FDA data and recent survey findings, the article underscores that containment failure is not purely theoretical, and that real-world variability across institutions may translate into inconsistent risk exposure.

Beyond clinical considerations, the article addresses a shifting regulatory and legal landscape, where the availability of FDA-cleared containment systems introduces new expectations around documentation, informed consent, and institutional oversight.

A key theme of the piece is the transition from individual surgical preference to institutional governance, prompting hospitals to evaluate whether containment practices are aligned with evolving standards of care, risk management, and defensibility.

To support this shift, the article outlines practical considerations for hospital leadership, including:

• formal review of containment systems

• standardization of documentation practices

• alignment of informed consent processes

• integration of risk management and legal perspectives

By positioning containment as a governance decision, the article contributes to a broader conversation around surgical safety, accountability, and the role of institutions in mitigating risk.

This work reflects ELAFY’s role in translating complex clinical and regulatory topics into clear, impactful narratives that support thought leadership, stakeholder engagement, and strategic positioning for MedTech innovators.

Read the article here.

In addition to content development and publication, ELAFY manages Ark Surgical’s LinkedIn presence and supported the distribution of this article across digital channels, ensuring visibility among clinicians, investors, and key stakeholders in the MedTech ecosystem.